RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @vnparikh: Purposeful, important work from @AartiAsnaniMD, @SarnoffCardio Scholar, dedicated physician-scientist, and an incredible near…
RT @datsunian: #cardioonc study from @AartiAsnaniMD @mariellecrosbie et al in furthering knowledge of what drives anthracycline CV TOX—& t…
RT @datsunian: #cardioonc study from @AartiAsnaniMD @mariellecrosbie et al in furthering knowledge of what drives anthracycline CV TOX—& t…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @datsunian: #cardioonc study from @AartiAsnaniMD @mariellecrosbie et al in furthering knowledge of what drives anthracycline CV TOX—& t…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @datsunian: #cardioonc study from @AartiAsnaniMD @mariellecrosbie et al in furthering knowledge of what drives anthracycline CV TOX—& t…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @datsunian: #cardioonc study from @AartiAsnaniMD @mariellecrosbie et al in furthering knowledge of what drives anthracycline CV TOX—& t…
#cardioonc study from @AartiAsnaniMD @mariellecrosbie et al in furthering knowledge of what drives anthracycline CV TOX—& to hopefully ID in future who is vulnerable @RRBaligaMD @OSUCardioOnc @onco_cardiology @CardioOncology @DLenihanICOS_MD @PrevCard
Purposeful, important work from @AartiAsnaniMD, @SarnoffCardio Scholar, dedicated physician-scientist, and an incredible near-peer mentor working on impactful questions in cardio-onc.
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
Changes in Citric Acid Cycle and Nucleoside Metabolism Are Associated with Anthracycline Cardiotoxicity in Patients with Breast Cancer #JCTR #MassSpec https://t.co/OGDSGGejI0
This is excellent work @AartiAsnaniMD @mariellesc1 and team. This may provide an opportunity for building more robust screening and finally preventive strategies.
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
RT @AartiAsnaniMD: Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mech…
Great work Aarti!
Interesting paper by @BIDMChealth faculty @AartiAsnaniMD @RobGersztenMD evaluating pathways involved in breast ca and cardiomyopathy
Pleased to share our paper on metabolic changes in plasma of pts with breast CA and cardiotox. Working toward early mechanism-based biomarkers @BIDMChealth @SarnoffCardio @mariellesc1 https://t.co/OCm5HoNarQ